Exporting pharmaceuticals, food, or cosmetics from India requires test reports that destination country regulators accept without question. Auriga Research provides USFDA-accepted, NABL-accredited, and WHO-recognized testing with certificates of analysis formatted for international filing.
We test per the destination country's pharmacopoeia and regulations — USP for the US, EP for Europe, BP for UK/Commonwealth, JP for Japan. One lab, every market.
CoAs issued on NABL-accredited letterhead with full method references, specifications, and results. Accepted by USFDA, EMA, TGA, and WHO procurement agencies.
We help you determine which tests are mandatory for your target market. No guesswork — just the right testing scope for clearance.
Express testing available for shipments held at port pending test reports. 3-5 day express TAT to minimize demurrage costs.
FDA Drug Establishment Registration. Reports accepted for ANDA/NDA submissions.
ISO/IEC 17025 under ILAC MRA. Accepted in 100+ countries.
WHO Prequalification for Global Fund and UN agency tenders.
Tell us your product and destination market. Our export compliance team will provide the right testing scope and a detailed quote.
Download a practical testing guide tailored to your industry — checklists, parameters, and regulatory tips in one place.
Get Free Guide Request a Quote InsteadNo thanks, I'll keep browsing